Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of its OneOme pharmacogenomics (PGx) ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, ...

Rosalind Brown had blood clots in her lungs. For years, her doctors tried to get the dose of a blood thinner just right to prevent the risk of a heart attack or other life-threatening complications ...

OneOme is pushing forward with its global expansion, announcing its first commercial break into three Asian territories on Wednesday. The Minneapolis startup’s RightMed kit, which tells patients what ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.